SummaryConsidering a large number of pathogen factors that enable high virulence of a microorganism such as Staphylococcus aureus (S. aureus), it is essential to see them through the continuous adaptation to the newly acquired mechanisms of the host immune response and efforts to overcome these, allowing the bacteria a perfect ecological niche for growth, reproduction, and location of new hosts. Past efforts to create a vaccine that would provide effective protection against infections caused by S. aureus remained without success. The reasons for this stem from the outstanding adaptability skills of this microorganism to almost all environmental conditions, the existence of a numerous virulence factors whose mechanisms of action are not well known, as well as insufficient knowledge of the immune response to S. aureus infections. This review article deals with this issue from another perspective and emphasizes actual knowledge on virulence factors and immune response to S. aureus.
References
1.
Chabelskaya S, Bordeau V, Felden B. Dual RNA regulatory control of a Staphylococcus aureus virulence factor. Nucleic Acids Research. 2014;42(8):4847–58.
2.
Park B, Nizet V, Liu GY. Role of Staphylococcus aureus Catalase in Niche Competition against Streptococcus pneumoniae. Journal of Bacteriology. 2008;190(7):2275–8.
3.
Fox JM, Letellier E, Oliphant CJ, Signoret N. TLR2-dependent pathway of heterologous down-modulation for the CC chemokine receptors 1, 2, and 5 in human blood monocytes. Blood. 2011;117(6):1851–60.
4.
Vandenesch F, Lina G, Henry T. Staphylococcus aureus Hemolysins, bi-component Leukocidins, and Cytolytic Peptides: A Redundant Arsenal of Membrane-Damaging Virulence Factors? Frontiers in Cellular and Infection Microbiology. 2.
Dastgheyb SS, Villaruz AE, Le KY, Tan VY, Duong AC, Chatterjee SS, et al. Role of Phenol-Soluble Modulins in Formation of Staphylococcus aureus Biofilms in Synovial Fluid. Infection and Immunity. 2015;83(7):2966–75.
7.
National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, Issued August 2001. American Journal of Infection Control. 2001;29(6):404–21.
8.
Edwin C. Quantitative determination of staphylococcal enterotoxin A by an enzyme-linked immunosorbent assay using a combination of polyclonal and monoclonal antibodies and biotin-streptavidin interaction. Journal of Clinical Microbiology. 1989;27(7):1496–501.
9.
Kim JH, van der Horst C, Mulrow CD, Corey GR. Staphylococcus aureus Meningitis: Review of 28 Cases. Clinical Infectious Diseases. 1989;11(5):698–706.
10.
Baddour LM, Barker LP, Christensen GD, Parisi JT, Simpson WA. Phenotypic variation of Staphylococcus epidermidis in infection of transvenous endocardial pacemaker electrodes. Journal of Clinical Microbiology. 1990;28(4):676–9.
11.
Liu Y, Kong F, Zhang X, Brown M, Ma L, Yang Y. Antimicrobial susceptibility ofStaphylococcus aureusisolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistantStaphylococcus aureusto be uncommon and heterogeneous. British Journal of Dermatology. 2009;161(6):1347–50.
12.
Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum Sensing in Staphylococcus aureus Biofilms. Journal of Bacteriology. 2004;186(6):1838–50.
13.
McAdow M, DeDent AC, Emolo C, Cheng AG, Kreiswirth BN, Missiakas DM, et al. Coagulases as Determinants of Protective Immune Responses against Staphylococcus aureus. Infection and Immunity. 2012;80(10):3389–98.
14.
Koch TK, Reuter M, Barthel D, Böhm S, van den Elsen J, Kraiczy P, et al. Staphylococcus aureus Proteins Sbi and Efb Recruit Human Plasmin to Degrade Complement C3 and C3b. PLoS ONE. 7(10):e47638.
15.
Mandell GL. Catalase, superoxide dismutase, and virulence of Staphylococcus aureus. In vitro and in vivo studies with emphasis on staphylococcal--leukocyte interaction. Journal of Clinical Investigation. 1975;55(3):561–6.
16.
Pignatari A, Pfaller M, Hollis R, Sesso R, Leme I, Herwaldt L. Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. Journal of Clinical Microbiology. 1990;28(9):1898–902.
17.
Lowy FD. Staphylococcus aureusInfections. New England Journal of Medicine. 1998;339(8):520–32.
18.
Johne B, Jarp J, Haaheim LR. Staphylococcus aureus exopolysaccharide in vivo demonstrated by immunomagnetic separation and electron microscopy. Journal of Clinical Microbiology. 1989;27(7):1631–5.
19.
Dos Santos Rodrigues JB, Pinto TS, De Oliveira CP, De Sousa Freitas FI, Vieira Pereira M do S, De Souza EL, et al. Lipolytic activity of Staphylococcus aureus from human wounds, animals, foods, and food-contact surfaces in Brazil. The Journal of Infection in Developing Countries. 8(08):1055–8.
20.
Abdelnour A, Arvidson S, Bremell T, Rydén C, Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infection and Immunity. 1993;61(9):3879–85.
21.
Miles G, Cheley S, Braha O, Bayley H. The Staphylococcal Leukocidin Bicomponent Toxin Forms Large Ionic Channels,. Biochemistry. 2001;40(29):8514–22.
22.
Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. The Lancet. 2002;359(9308):753–9.
23.
Giese B, Dittmann S, Paprotka K, Levin K, Weltrowski A, Biehler D, et al. Staphylococcal Alpha-Toxin Is Not Sufficient To Mediate Escape from Phagolysosomes in Upper-Airway Epithelial Cells. Infection and Immunity. 2009;77(9):3611–25.
24.
Reed P, Atilano ML, Alves R, Hoiczyk E, Sher X, Reichmann NT, et al. Staphylococcus aureus Survives with a Minimal Peptidoglycan Synthesis Machine but Sacrifices Virulence and Antibiotic Resistance. PLOS Pathogens. 11(5):e1004891.
25.
Sadovskaya I, Vinogradov E, Flahaut S, Kogan G, Jabbouri S. Extracellular Carbohydrate-Containing Polymers of a Model Biofilm-Producing Strain, Staphylococcus epidermidis RP62A. Infection and Immunity. 2005;73(5):3007–17.
26.
Branger C, Goullet P, Boutonnier A, Fournier JM. Correlation between esterase electrophoretic types and capsular polysaccharide types 5 and 8 among methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus. Journal of Clinical Microbiology. 1990;28(1):150–1.
27.
Ko YP, Kuipers A, Freitag CM, Jongerius I, Medina E, van Rooijen WJ, et al. Phagocytosis Escape by a Staphylococcus aureus Protein That Connects Complement and Coagulation Proteins at the Bacterial Surface. PLoS Pathogens. 9(12):e1003816.
28.
Grosz M, Kolter J, Paprotka K, Winkler AC, Schäfer D, Chatterjee SS, et al. Cytoplasmic replication ofStaphylococcus aureusupon phagosomal escape triggered by phenol-soluble modulin α. Cellular Microbiology. 2014;16(4):451–65.
29.
Boutonnier A, Nato F, Bouvet A, Lebrun L, Audurier A, Mazie JC, et al. Direct testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus. Journal of Clinical Microbiology. 1989;27(5):989–93.
30.
Nicholas RO, Li T, McDevitt D, Marra A, Sucoloski S, Demarsh PL, et al. Isolation and Characterization of a sigB Deletion Mutant of Staphylococcus aureus. Infection and Immunity. 1999;67(7):3667–9.
31.
Fournier JM, Bouvet A, Boutonnier A, Audurier A, Goldstein F, Pierre J, et al. Predominance of capsular polysaccharide type 5 among oxacillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology. 1987;25(10):1932–3.
32.
Goerke C, Pantucek R, Holtfreter S, Schulte B, Zink M, Grumann D, et al. Diversity of Prophages in Dominant Staphylococcus aureus Clonal Lineages. Journal of Bacteriology. 2009;191(11):3462–8.
33.
Ibberson CB, Jones CL, Singh S, Wise MC, Hart ME, Zurawski DV, et al. Staphylococcus aureus Hyaluronidase Is a CodY-Regulated Virulence Factor. Infection and Immunity. 2014;82(10):4253–64.
34.
Kobayashi SD, DeLeo FR. Staphylococcus aureus Protein A Promotes Immune Suppression. mBio. 2013;4(5).
35.
Rubtsova MYu, Ulyashova MM, Edelstein MV, Egorov AM. Oligonucleotide microarrays with horseradish peroxidase-based detection for the identification of extended-spectrum β-lactamases. Biosensors and Bioelectronics. 2010;26(4):1252–60.
36.
Tajima A, Iwase T, Shinji H, Seki K, Mizunoe Y. Inhibition of Endothelial Interleukin-8 Production and Neutrophil Transmigration byStaphylococcus aureusBeta-Hemolysin. Infection and Immunity. 2009;77(1):327–34.
37.
BERGDOLL M. TOXIC SHOCK SYNDROME TOXIN. The Lancet. 1984;324(8404):691.
38.
White MJ, Boyd JM, Horswill AR, Nauseef WM. Phosphatidylinositol-Specific Phospholipase C Contributes to Survival of Staphylococcus aureus USA300 in Human Blood and Neutrophils. Infection and Immunity. 2014;82(4):1559–71.
39.
Hartstein AI, Mulligan ME, Morthland VH, Kwok RY. Recurrent Staphylococcus aureus bacteremia. Journal of Clinical Microbiology. 1992;30(3):670–4.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
